XML 30 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Common stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2023   205,771      
Beginning balance at Dec. 31, 2023 $ (455,528) $ 2,058 $ 1,222,236 $ 1,337 $ (1,681,159)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (35,379)       (35,379)
Other comprehensive income (loss) (566)     (566)  
Exercise of stock options, net (in shares)   176      
Exercise of stock options 552 $ 2 550    
Vesting of restricted stock units (in shares)   155      
Vesting of restricted stock units 0 $ 1 (1)    
Shares withheld for taxes for vesting of restricted stock units (in shares)   (8)      
Shares withheld for taxes for vesting of restricted stock units (38)   (38)    
Employee stock purchase plan sales, net (in shares)   251      
Employee stock purchase plan sales 1,129 $ 2 1,127    
Issuance of shares to directors in lieu of cash retainer (in shares)   2      
Issuance of shares to directors in lieu of cash retainer 11   11    
Stock-based compensation expense 13,652   13,652    
Common stock, shares outstanding, ending balance (in shares) at Mar. 31, 2024   206,347      
Ending balance at Mar. 31, 2024 (476,167) $ 2,063 1,237,537 771 (1,716,538)
Common stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2023   205,771      
Beginning balance at Dec. 31, 2023 (455,528) $ 2,058 1,222,236 1,337 (1,681,159)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (62,086)        
Other comprehensive income (loss) 956        
Common stock, shares outstanding, ending balance (in shares) at Sep. 30, 2024   207,119      
Ending balance at Sep. 30, 2024 (468,563) $ 2,071 1,270,318 2,293 (1,743,245)
Common stock, shares outstanding, beginning balance (in shares) at Mar. 31, 2024   206,347      
Beginning balance at Mar. 31, 2024 (476,167) $ 2,063 1,237,537 771 (1,716,538)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (12,674)       (12,674)
Other comprehensive income (loss) (214)     (214)  
Exercise of stock options, net (in shares)   80      
Exercise of stock options 264 $ 1 263    
Vesting of restricted stock units (in shares)   200      
Vesting of restricted stock units 0 $ 2 (2)    
Issuance of shares to directors in lieu of cash retainer (in shares)   2      
Issuance of shares to directors in lieu of cash retainer 12   12    
Stock-based compensation expense 13,173   13,173    
Common stock, shares outstanding, ending balance (in shares) at Jun. 30, 2024   206,629      
Ending balance at Jun. 30, 2024 (475,606) $ 2,066 1,250,983 557 (1,729,212)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (14,033)       (14,033)
Other comprehensive income (loss) 1,736     1,736  
Exercise of stock options, net (in shares)   262      
Exercise of stock options 1,362 $ 3 1,359    
Vesting of restricted stock units (in shares)   66      
Vesting of restricted stock units 0 $ 1 (1)    
Employee stock purchase plan sales, net (in shares)   161      
Employee stock purchase plan sales 723 $ 1 722    
Issuance of shares to directors in lieu of cash retainer (in shares)   1      
Issuance of shares to directors in lieu of cash retainer 6   6    
Stock-based compensation expense 17,249   17,249    
Common stock, shares outstanding, ending balance (in shares) at Sep. 30, 2024   207,119      
Ending balance at Sep. 30, 2024 $ (468,563) $ 2,071 1,270,318 2,293 (1,743,245)
Common stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2024 208,543 208,543      
Beginning balance at Dec. 31, 2024 $ (475,934) $ 2,085 1,291,100 921 (1,770,040)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 32       32
Other comprehensive income (loss) 211     211  
Exercise of stock options, net (in shares)   286      
Exercise of stock options 1,229 $ 3 1,226    
Vesting of restricted stock units (in shares)   184      
Vesting of restricted stock units 0 $ 2 (2)    
Shares withheld for taxes for vesting of restricted stock units (in shares)   (8)      
Shares withheld for taxes for vesting of restricted stock units (56)   (56)    
Employee stock purchase plan sales, net (in shares)   202      
Employee stock purchase plan sales 1,217 $ 2 1,215    
Issuance of shares to directors in lieu of cash retainer (in shares)   1      
Issuance of shares to directors in lieu of cash retainer 6   6    
Stock-based compensation expense 21,368   21,368    
Common stock, shares outstanding, ending balance (in shares) at Mar. 31, 2025   209,208      
Ending balance at Mar. 31, 2025 $ (451,927) $ 2,092 1,314,857 1,132 (1,770,008)
Common stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2024 208,543 208,543      
Beginning balance at Dec. 31, 2024 $ (475,934) $ 2,085 1,291,100 921 (1,770,040)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 18,016        
Other comprehensive income (loss) $ 219        
Common stock, shares outstanding, ending balance (in shares) at Sep. 30, 2025 210,522 210,522      
Ending balance at Sep. 30, 2025 $ (387,889) $ 2,105 1,360,890 1,140 (1,752,024)
Common stock, shares outstanding, beginning balance (in shares) at Mar. 31, 2025   209,208      
Beginning balance at Mar. 31, 2025 (451,927) $ 2,092 1,314,857 1,132 (1,770,008)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 5,085       5,085
Other comprehensive income (loss) 514     514  
Exercise of stock options, net (in shares)   560      
Exercise of stock options 3,421 $ 6 3,415    
Vesting of restricted stock units (in shares)   136      
Vesting of restricted stock units 0 $ 1 (1)    
Issuance of shares to directors in lieu of cash retainer (in shares)   1      
Issuance of shares to directors in lieu of cash retainer 9   9    
Stock-based compensation expense 21,304   21,304    
Common stock, shares outstanding, ending balance (in shares) at Jun. 30, 2025   209,905      
Ending balance at Jun. 30, 2025 (421,594) $ 2,099 1,339,584 1,646 (1,764,923)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 12,899       12,899
Other comprehensive income (loss) (506)     (506)  
Exercise of stock options, net (in shares)   300      
Exercise of stock options 1,566 $ 3 1,563    
Vesting of restricted stock units (in shares)   147      
Vesting of restricted stock units 0 $ 1 (1)    
Employee stock purchase plan sales, net (in shares)   167      
Employee stock purchase plan sales 1,081 $ 2 1,079    
Issuance of shares to directors in lieu of cash retainer (in shares)   3      
Issuance of shares to directors in lieu of cash retainer 21   21    
Stock-based compensation expense $ 18,644   18,644    
Common stock, shares outstanding, ending balance (in shares) at Sep. 30, 2025 210,522 210,522      
Ending balance at Sep. 30, 2025 $ (387,889) $ 2,105 $ 1,360,890 $ 1,140 $ (1,752,024)